These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1916490)
1. Inhibitory effect of a cholecystokinin antagonist on the proliferative response of the pancreas to pancreatobiliary diversion. Watanapa P; Efa EF; Beardshall K; Calam J; Sarraf CE; Alison MR; Williamson RC Gut; 1991 Sep; 32(9):1049-54. PubMed ID: 1916490 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion. Watanapa P; Flaks B; Oztas H; Deprez PH; Calam J; Williamson RC Br J Cancer; 1993 Apr; 67(4):663-7. PubMed ID: 8471422 [TBL] [Abstract][Full Text] [Related]
3. Role of cholecystokinin in pancreatic adaptation to massive enterectomy. Watanapa P; Egan M; Deprez PH; Calam J; Sarraf CE; Alison MR; Williamson RC Gut; 1992 Jul; 33(7):959-64. PubMed ID: 1644338 [TBL] [Abstract][Full Text] [Related]
4. Implication of cholecystokinin in pancreatic adaptation after biliopancreatic bypass in the rat. Evrard S; Hoeltzel A; Aprahamian M; Bernard C; Mutter D; Marescaux J; Damgé C Digestion; 1994; 55(4):208-13. PubMed ID: 7520400 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of the cholecystokinin antagonist loxiglumide on pancreatic exocrine secretion and pancreatic growth in conscious rats. Taguchi S; Green GM; Nakano I; Hatta Y Int J Pancreatol; 1992 Apr; 11(2):67-73. PubMed ID: 1607730 [TBL] [Abstract][Full Text] [Related]
6. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats. Papp M; Varga G; Folly G Acta Physiol Hung; 1991; 78(1):61-7. PubMed ID: 1722380 [TBL] [Abstract][Full Text] [Related]
7. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat. Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Digestion; 1989; 42(2):61-9. PubMed ID: 2475379 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Niederau C; Liddle RA; Williams JA; Grendell JH Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964 [TBL] [Abstract][Full Text] [Related]
9. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631 [TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats. Gasslander T; Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF Scand J Gastroenterol; 1990 Oct; 25(10):1060-5. PubMed ID: 2263879 [TBL] [Abstract][Full Text] [Related]
11. Effect of proglumide on rat pancreatic growth. Yamaguchi T; Tabata K; Johnson LR Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150 [TBL] [Abstract][Full Text] [Related]
12. Severe subcellular damage in the rat exocrine pancreas after pancreatobiliary diversion. Sarraf CE; Watanapa P; Emons VE; Williamson RC; Alison MR Pancreas; 1993 May; 8(3):338-45. PubMed ID: 8483876 [TBL] [Abstract][Full Text] [Related]
13. Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB Gastroenterology; 1989 Feb; 96(2 Pt 1):462-9. PubMed ID: 2910761 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of pancreatic growth induced by pancreatico-biliary diversion in the rat. Inhibition by proglumide, benzotript, and ranitidine. Miazza BM; Turberg Y; Guillaume P; Hahne W; Chayvialle JA; Loizeau E Scand J Gastroenterol Suppl; 1985; 112():75-83. PubMed ID: 2409583 [TBL] [Abstract][Full Text] [Related]
15. Pancreatobiliary Diversion in the Mouse. Chen X; Qiu S; Li Q; Hu L; Yao C; Xu X; Wang F Eur Surg Res; 2020; 61(4-5):130-135. PubMed ID: 33260177 [TBL] [Abstract][Full Text] [Related]
16. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats. Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885 [TBL] [Abstract][Full Text] [Related]
17. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat. Sperti C; Militello C; Rovati L; Behboo R; Khajeturian E; Perasole A; Alaggio R; Pedrazzoli S J Surg Oncol; 1994 Sep; 57(1):11-6. PubMed ID: 8065144 [TBL] [Abstract][Full Text] [Related]
18. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats. Kanemitsu D; Sakagami J; Motoyoshi T; Nakajima T; Kataoka K Pancreas; 2006 Mar; 32(2):190-6. PubMed ID: 16552340 [TBL] [Abstract][Full Text] [Related]
19. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats. Li P; Lee KY; Chang TM; Chey WY Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665 [TBL] [Abstract][Full Text] [Related]
20. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide. Meijers M; Appel MJ; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA Carcinogenesis; 1992 Sep; 13(9):1525-8. PubMed ID: 1394835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]